The Longevity Genes in Founder Populations Project

Part of paid clinical trials in New York, New York.

Sponsor
Albert Einstein College of Medicine
Study ID
NCT00707694
Status
Recruiting

Conditions

  • Extreme Longevity

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Accepted

Study Details

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Key Dates

Start date
Jul 31, 1998
Status verified
Dec 2025
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Probands
    Ashkenazi Jews ages 95 and older
  • Arm: Offspring
    Ashkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
  • Arm: Controls
    Ashkenazi Jewish people with no family history of longevity

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Private HomesNew YorkNew York-
Wanda I Guzman, BA
718-430-3838
Hebrew Home RiverdaleRiverdaleNew York10471
Charlotte Dell, LMSW
718-581-1139

Find similar trials in New York, NY